arrow
T

Tor Åge Myklebust

Norwegian Institute of Public Health
H指数:31
被引数:4,530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Persistent redundant nerve roots two years after decompression for lumbar spinal stenosis: clinical outcomes and radiologic findings—a secondary analysis of the NORDSTEN spinal stenosis trial

减压术后两年仍存在的冗余神经根:临床结果和影像学发现——NORDSTEN脊柱狭窄试验的二次分析

2026-11-050
OAAI
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial

抗肿瘤坏死因子撤药或长期治疗在溃疡性结肠炎中的应用(BIOSTOP):一项多中心开放标签随机对照试验

2026-08-060
PRE
Heart rate trends in healthy newborns ≥35+0 weeks' gestation after caesarean delivery with extrauterine placental transfusion and physiology-based cord clamping: a Norwegian observational study (INTACT-3)

≥35+0周胎龄的健康新生儿在剖宫产、子宫外胎盘输血和基于生理的脐带结扎后的心率趋势:一项挪威观察性研究(INTACT-3)

2026-04-200
PRE
Predictors for Unsuccessful Outcome of Lumbar Spinal Stenosis Surgery A Secondary Analysis of the 2 Randomized NORDSTEN Trials

腰椎管狭窄手术预后不佳的预测因素:两项随机NORDSTEN试验的二次分析

Spine
IF3.5
2026-04-151
PRE
Changes in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population-based cohort study
2026-01-210
OAAI
Effects of digital stress-management interventions in breast cancer patients 18 months after intervention access

数字压力管理干预在乳腺癌患者中的应用效果:干预接入18个月后的研究

2026-01-010
OA
Supplementation with a Salmon Bone Complex (CalGo®) Preserves Femoral Neck BMD and Attenuates Lumbar Spine Loss: A 24-Month Randomized, Placebo-Controlled Trial

补充鲑鱼骨复合物(CalGo®)可维持股骨颈骨密度并减轻腰椎骨量丢失:一项为期24个月的随机、安慰剂对照试验

2025-10-250
OAAI